Research decides – but – Patients inspires
DanCann Pharma A/S was founded in 2018 and is a Danish pharmaceutical biotechnology company powered by cannabinoids. DanCann Pharma is focused on discovering, developing, manufacturing, and commercializing of novel cannabinoid therapeutics in a broad range of disease areas.
DanCann Pharma was established due to the poor access for cannabinoid-based drugs and pharmaceuticals shortly after the establishment of the new Pilot Programme with medical cannabis in Denmark.
After a life with type 1 diabetes, Jeppe Krog Rasmussen decided his life should be dedicated helping others who’s lives like his had been impacted by health issues. He formed a partnership with Morten Martinsen, another diabetes patient, and together they determined that medical cannabis should become their way of helping the world.
From this foundation of care, DanCann Pharma will grow with a passion to improve health and life quality for patients with challenges. We challenge status quo, based on knowledge and innovation and we innovate life-changing technology – and if that means we need to challenge conventions, then that is what we do.